ALB and non-Hodgkin lymphoma: Patients on chemotherapy who developed VTE had significantly higher ANC, neutrophil/lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-lymphocyte ratio (PLR) ratio, and LDH levels, while they had significantly lower absolute lymphocytic counts (ALC), mean platelet volume (MPV) and serum albumin levels in comparison to NHL patients who did not have VTE Table 4.